What is known and objective The application of biologics to treat inflammatory bowel
disease (IBD), including Crohn's disease and ulcerative colitis, is well established. Our aim …

Background and Objectives: Patients affected by inflammatory bowel diseases (IBDs) are
complex patients with various problems from a clinical and psychological point of view. This …

Objective Medication adherence is crucial in the management of Crohn's disease (CD), and
yet the adherence remains low. This study aimed to develop machine learning models that …

The intestinal epithelium with its barrier function controls the antigen trafficking from the
intestinal lumen to the submucosa. Zonulin, a precursor of haptoglobin-2, plays a key role in …

Abstract Background Inflammatory bowel diseases (IBDs) require continuous clinical
management; poor medication adherence may result in worse disease outcomes and …

Inflammatory bowel disease (IBD) management is typified by a long-term medication
regimen which can comprise multiple medications prescribed in different combinations …

Aims Inflammatory bowel disease (IBD) management entails long‐term medication therapy.
Worse disease outcomes and reduced quality of life might arise from poor medication …

Introduction The lockdown period due to the coronavirus disease 2019 (COVID-19) in Spain
probably had a significant emotional impact on chronic patients and hence on those who are …

BACKGROUND: Inflammatory bowel disease (IBD) is a relapsing chronic disease of the
gastrointestinal (GI) tract. Among IBD patients, anemia is more frequent than in general …

Background Ulcerative colitis (UC) is a life-long disease characterised by flare ups and
periods of remission. This market research sponsored by Janssen-Cilag Ltd was designed …